Is there an increased risk of second primaries following prostate irradiation?

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 2, 1998, Pages 251-255

  Movsas, Benjamin ^a   Hanlon, Alexandra L ^a   Pinover, Wayne ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Prostate; Radiotherapy; Secondary neoplasms

Indexed keywords

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION CARCINOGENESIS; RISK FACTOR; SECOND CANCER;

EID: 0032076267     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00570-1     Document Type: Article

References (19)

1. Cahan W.G., Woodard H.Q., Higinbotham N.L., Stewart F.W., Coley B.L. Sarcoma arising in irradiated bone. Cancer. 1:1948;3-28.
2. Freedman G.M., Hanlon A.L., Lee W.R., Hanks G.E. Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;243-250.
3. Goldstein A.M., Goldin L.R., Dracopoli N.C., Clark W.H. Jr, Tucker M.A.A. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi. Am. J. Hum. Genet. 58:1996;1050-1056.
4. Greenberg R.S., Rustin E., Scott-Clark W. Risk of genitourinary malignancies after cancer of the prostate. Cancer. 61:1988;396-401.
5. Haluska F.G., Housman D.E. Recent advances in the molecular genetics of malignant melanoma. Cancer Surveys. 25:1995;277-292.
6. Hanks G.E., Hanlon A.L., Schultheiss T.E., Freedman G.M., Hunt M., Pinover W.H., Movsas B. Conformal external beam treatment of prostate cancer. Urology. 50:1997;87-92.
7. Hanks, G. E.; Schultheiss, T. E.; Hunt, M. Clinical experience with 3D radiotherapy treating prostate cancer. Proceedings of International Symposium on 3D radiation treatment of prostate cancer, St. Louis, MO; 1993.
8. Isshiki K., Elder D.E., Guerry D., Linnenbach A.J. Chromosome 10 allelic loss in malignant melanoma. Genes Chromosomes Cancer. 8:1993;178-184.
9. Ittmann M.M. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Prostate. 28:1996;275-281.
10. Kleinerman R.A., Lieberban J., Li F. Second cancer following cancer of the male genital system in Connecticut 1935-1982. Natl. Cancer Inst. Monog. 68:1985;139-147.
11. Konig J.J., Teubel W., Romijn J.C., Schroder F.H., Hagemeijer A. Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers. Hum. Pathol. 27:1996;720-727.
12. Liskow A., Neugut A., Benson M., Olsson C.A., Birkhoff J., Chang C.H. Multiple primary neoplasms in association with prostate cancer in black and white patients. Cancer. 59:1987;380-384.
13. Lynch H.T., Larsen A.L., Magnuson C.W., Krush A.J. Prostate carcinoma and multiple primary malignancies. Cancer. 19:1966;1891-1897.
14. Osterlind A., Rorth M., Prener A. Second cancer following cancer of the male genital system in Denmark, 1943-80. Natl. Cancer Inst. Monogr. 68:1985;341-347.
15. Pandha H.S., Waxman J. Multiple primary cancers in association with prostate cancer. Cancer Surveys. 23:1995;235-246.
16. Qi H., Dal Cin P., Van de Voorde W., Elgamal A.A., Van Poppel H., Baert L., Van Den Berghe H. del. (1) (q12) in adenocarcinomas of the prostate. Cancer Gene. Cytogenet. 87:1996;79-81.
17. Smith J.R., Freije D., Carpten J.D., Gronberg H., Xu J., Isaacs S.D., et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a Genome-Wide search. Science. 274:1996;1371-1374.
18. Soffen E.M., Hanks G.E., Hwang C.C., Chu J. CH. Conformal static field therapy for low volume low grade prostate cancer with rigid immobilization. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;142-146.
19. Zucali R., Luini A., Del Vecchio M., Sacchini V., Sverzellati E., Stucchi C. Contralateral breast cancer after limited surgery plus radiotherapy of early mammary tumors. Eur. J. Surg. Oncol. 13:1987;413-417.